Trial intelligence / Profile preview

Desmopressin versus intranasal ketamine versus placebo for renal colic pain

IRCT20180129038549N12Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jun 2021
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3, randomised trial in Renal colic comparing Desmopressin + ketorolac, Ketamine + ketorolac and Placebo + ketorolac (3 arms). Primary endpoint: Pain severity by visual analog scale at 60 minutes. Started Jun 2021; status: completed.

02

Drugs

desmopressinketamineketorolac
03

Conditions

Renal colic

Beyond the preview

Go deeper on IRCT20180129038549N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180129038549N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call